For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Scope of the Report:
This report focuses on the Platinum based Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.
The worldwide market for Platinum based Cancer Drug is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 1580 million US$ in 2023, from 1290 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Hengrui Medicine
- ASK Pharma
- Yi Bai Pharmaceutical
- Qilu Pharmaceutical
- Dr Reddy's Laboratories
- Sun Pharma
- Accord Healthcare
- SK Chemicals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Colorectal Cancer
- Ovarian Cancer
- Lung Cancer
There are 15 Chapters to deeply display the global Platinum based Cancer Drug market.
Chapter 1, to describe Platinum based Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Platinum based Cancer Drug, with sales, revenue, and price of Platinum based Cancer Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Platinum based Cancer Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source